Clinical Trial Supplies Global Market Forecast Report and Company Analysis 2025-2033, Profiles of Almac Group, Biocair, DHL, Thermo Fisher Scientific, Marken, Paraxel, Sharp Services, and PCI Pharma Services
| TGBLX Fund | USD 10.32 0.14 1.34% |
Slightly above 62% of T Rowe's investor base is looking to short. The analysis of overall sentiment of trading T Rowe Price mutual fund suggests that many investors are alarmed at this time. T Rowe's investing sentiment can be driven by a variety of factors including economic data, T Rowe's earnings reports, geopolitical events, and overall market trends.
TGBLX |
Rising chronic disease incidence, tightening regulations, globalization of clinical trials, advances in biotechnology, introduction of biosimilars and orphan drugs, and newer technologies such as blockchain and IoT in supply chain management emerge as the key drivers for the Clinical Trial Supplies market
Read at newswire.com
 |
T Rowe Fundamental Analysis
We analyze T Rowe's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of T Rowe using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of T Rowe based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
T Rowe is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
T Rowe Price Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with T Rowe mutual fund to make a market-neutral strategy. Peer analysis of T Rowe could also be used in its relative valuation, which is a method of valuing T Rowe by comparing valuation metrics with similar companies.
Peers
T Rowe Related Equities
| GABFX | Gmo Asset | 0.96 | ||||
| JAAIX | Alternative Asset | 0.12 | ||||
| HCVAX | The Hartford | 0.44 | ||||
| PBLIX | Pnc Balanced | 0.97 | ||||
| PLKTX | Principal Lifetime | 1.14 | ||||
| TADGX | T Rowe | 1.42 | ||||
| TRBCX | T Rowe | 2.66 |
Other Information on Investing in TGBLX Mutual Fund
T Rowe financial ratios help investors to determine whether TGBLX Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TGBLX with respect to the benefits of owning T Rowe security.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |